Exact Sciences Raises $27.1M in Public Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences today said that it has raised net proceeds of $27.1 million in a public offering of common stock.

The company sold a total of 3,593,750 shares of its common stock at $8 per share. The underwriters on the offering exercised their over-allotment option in full, Exact Sciences said.

RW Baird acted as sole book-running manager in the offering. William Blair was co-manager.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.